If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Industry Recognition

31 Jan 2006 07:02

Sopheon PLC31 January 2006 Embargoed Release: 07:00hrs Tuesday 31st January 2006 Sopheon Plc ('Sopheon' or the 'Company') Leading IT Market Research Firm Cites Sopheon As First-Mover In Taking Advantage of Major Market Trend New Report Says Company Well-Positioned to Benefit From Convergence of Product Life Cycle and Portfolio Management Solutions Sopheon Plc, the international software and services company, announces todaythat global IT research and advisory firm IDC has published a profile analyzingSopheon and its flagship Accolade process and product portfolio managementsystem. The report credits Sopheon with early recognition of the convergence ofproduct life cycle management (PLM) and project portfolio management (PPM)solutions and taking effective action to capitalize on this trend, which IDCcharacterizes as a major, new market force. (Source: IDC, "Sopheon's AccoladeBreaking out in PLM and Portfolio Management Convergence," Doc #34274.) In an IDC Product Flash, analysts Evan Quinn and Gisela Wilson examine Sopheon'smarket position and the evolution of its flagship offering. From the analysts'perspective, Accolade's functional focus on improving the product developmentprocess, including recent enhancements to the solution, has separated it fromtraditional project portfolio management software and is positively impactingSopheon's business outlook. The report observes that Sopheon seems "particularly well positioned to ride thePLM/PPM convergence trend given its differentiated approach." Earmarks of thatapproach, according to IDC's analysis, include built-in support for the widelyused Stage-Gate(R) product development process framework; portals and analyticstargeted for process industries; integration with Microsoft(R) Project; andstrong portfolio management features. The commentary points to Sopheon'sexpanding sales pipeline, increasing deal size and its stepped-up pursuit ofindirect channel sales partnerships as validation that the company is movinginto a new phase of growth. "Sopheon stands out as a first mover in PLM/PPM convergence," the reportconcludes, "and possesses a position of leverage in Microsoft's businessapplication partnership community. Accolade is ahead of many of its moreestablished competitors in terms of how to leverage collaboration, portal, andcontent technologies for innovation management." "Generic project management tools can provide great value operationally," saidAndy Michuda, chief executive officer of Sopheon, "But they don't address theneeds of corporate executives for information that can help them make strategicproduct-development decisions. There's a growing body of evidence that one ofthe most important characteristics separating innovation leaders from the packis that they put in place a strong product innovation process and support itwith superior project management skills. Accolade enables organizations toquickly develop these capabilities as a sustainable competitive advantage. Oursolution was built from the ground up to manage projects within the businesscontext of the new product development process. And it has demonstrated that itcan produce break-through results. Being recognized as a "first-mover" in thisemerging market of applying project management best-practices to the productlife cycle management process is strong validation of our unique application andstrategic focus. Having this recognition come from one of the world's topindependent IT research and advisory firms is especially affirming." Sopheon Accolade(R) is a registered trademark of Sopheon plc. Stage-Gate(R) is a registered trademark of the Product Development Institute. Microsoft(R) is a registered trademark of Microsoft Corporation.All other trademarks and registered trademarks are the soleproperty of their respective owners. About Sopheon Sopheon (LSE: SPE) is an international provider of software and services thathelp organizations improve the business impact of product development. TheSopheon Accolade(R) product development system automates gate- or phase-basedproduct development processes and provides strategic decision support thatallows companies to improve innovation, cut product development spending wasteand shorten time-to-market. Sopheon's Monitor software operates as a "readingrobot" that automatically reviews, filters, analyzes and pushes relevant contentto healthcare and engineering professionals to enable effective compliance withprotocols, standards and regulations. Sopheon is listed on the AIM Market of theLondon Stock Exchange and on the Euronext in the Netherlands. For moreinformation, please visit www.sopheon.com. For further information contact: Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685 735 Arif Karimjee, CFO Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245 1100Andrew Tan + 44 (0) 7957 203 685 Floor van Maaren Citigate First Financial Tel : + 31 (0) 205 754 010 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Dec 20137:00 amRNSDirector/PDMR Shareholding
5th Dec 20137:00 amRNSCorporate Update
19th Nov 20137:00 amRNSSopheon Delivers Accolade® Release 9.0
7th Nov 20137:00 amRNSInterim Management Statement
11th Sep 20133:00 pmRNSHolding(s) in Company
4th Sep 20133:00 pmRNSHolding(s) in Company
22nd Aug 20137:00 amRNSInterim Results
15th Aug 20133:00 pmRNSHolding(s) in Company
29th Jul 20133:00 pmRNSHolding(s) in Company
26th Jul 20137:00 amRNSTrading Update
15th Jul 20134:15 pmRNSHolding(s) in Company
28th Jun 20133:00 pmRNSTotal Voting Rights
27th Jun 20133:00 pmRNSHolding(s) in Company
19th Jun 20133:42 pmRNSHolding(s) in Company
19th Jun 20137:00 amRNSNew capabilities with Accolade(R) 8.3
14th Jun 20132:00 pmRNSContract Win
12th Jun 201312:00 pmRNSResult of AGM & GM
12th Jun 20137:00 amRNSAGM Statement
4th Jun 20137:00 amRNSIssue of Shares
2nd May 20137:00 amRNSInterim Management Statement
21st Mar 20137:00 amRNSPreliminary Results
30th Jan 20137:00 amRNSTrading Update
23rd Jan 20137:00 amRNSLaunch of Accolade 8.2
7th Dec 201211:36 amPRNHolding(s) in Company
8th Nov 20127:00 amPRNInterim Management Statement
1st Oct 20127:00 amRNSHolding(s) in Company
1st Oct 20127:00 amRNSDirectors' Options
24th Sep 20127:00 amRNSMarket Transfer to NYSE Alternext Concluded
23rd Aug 20127:00 amRNSAmendment to Terms of Convertible Loan Stock
23rd Aug 20127:00 amRNSInterim Results
23rd Jul 20127:00 amRNSTrading Update
13th Jun 20123:14 pmRNSResult of AGM
13th Jun 20127:00 amRNSAGM Statement
15th May 20127:00 amRNSAmendment to terms of Convertible Loan Stock
3rd May 20127:00 amRNSInterim Management Statement
25th Apr 20127:00 amRNSLaunch of Accolade 8.0
22nd Mar 20127:00 amRNSPreliminary Results
16th Feb 20127:00 amRNSTop 10 Solution Provider to CGM
31st Jan 20127:00 amRNSTrading Update
23rd Dec 201112:32 pmRNSExtension of GEM Equity Line
23rd Dec 201112:29 pmRNSTrading Update
5th Dec 201112:40 pmRNSHolding(s) in Company
3rd Nov 20117:00 amRNSInterim Management Statement
25th Aug 20117:00 amRNSInterim Results
25th Jul 20117:00 amRNSTrading Statement
23rd Jun 20112:15 pmRNSDirector/PDMR Shareholding
15th Jun 20117:00 amRNSAGM Statement
5th May 20117:00 amRNSInterim Management Statement
24th Mar 20117:00 amRNSPreliminary Results
10th Feb 20117:00 amPRNAppointment of Adviser

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.